Strides Pharma Recommends Deloitte as New Auditor

Strides Pharma board recommends appointing Deloitte Haskins & Sells LLP as statutory auditors for a five-year term starting FY28.
The appointment will replace incumbent B S R & Co. LLP, which completes its second five-year term in 2027.
Shareholder approval for the auditor change will be sought at the 36th Annual General Meeting in 2027.
The board meeting was held on May 18, 2026, based on the recommendation of the Audit Committee.